The inhibition of TGF-β signaling with an inhibitor of the TGF-β type 1 receptor (TGFBR1) prevented the formation of this pre-metastatic niche and pancreatic cancer metastasis to the liver in a mouse model [5]. The gene discussed is TGFB1; the disease is pancreatic neoplasm.